David Scadden's Net Worth
$5.55 Million
Who is David Scadden?
David Scadden has an estimated net worth of $5.55 Million. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS, INC., Editas Medicine, Inc., and Magenta Therapeutics, Inc..
SEC CIK
David Scadden's CIK is 0001707715
Past Insider Trading and Trends
2018 was David Scadden's most active year for acquiring shares with 5 total transactions. David Scadden's most active month to acquire stocks was the month of May. 2018 was David Scadden's most active year for disposing of shares, totalling 3 transactions. David Scadden's most active month to dispose stocks was the month of April. 2018 saw David Scadden paying a total of $115,688.00 for 41,976 shares, this is the most they've acquired in one year. In 2018 David Scadden cashed out on 72,548 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AGIOS PHARMACEUTICALS, INC. (AGIO) Snapshot price: $23.79
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +28.01% | 3.39K |
—
|
—
| 15.48K |
Jun 13
| |||
Form 4
| +69.87% | 4.97K |
—
|
—
| 12.1K |
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +28.64% | 1.58K |
—
|
—
| 7.12K |
May 20
| |||
Form 4
| +43.80% | 1.69K |
—
|
—
| 5.54K |
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| +95.28% | 1.88K |
—
|
—
| 3.85K |
May 28 - May 29
| |||
Form 4
| +245.18% | 1.4K |
—
|
—
| 1.97K |
May 29 - May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
| +53.91% | 200 |
$83.44 | $16,688.00 | 571 |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Editas Medicine, Inc. (EDIT) Snapshot price: $7.16
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Magenta Therapeutics, Inc. (DNTH) Snapshot price: $23.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| +17.92% | 34.68K |
$15.00 |
—
| 228.18K |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Carisma Therapeutics Inc. (CARM) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||